Wordt geladen...
Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
AIMS: Ivabradine has been approved in heart failure with reduced ejection fraction (HFrEF) and elevated heart rate despite guideline‐directed medical therapy (GDMT) to reduce cardiovascular (CV) death and hospitalization for worsening HF. The median value of 77 b.p.m. is the lower bound selected for...
Bewaard in:
| Gepubliceerd in: | ESC Heart Fail |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6989297/ https://ncbi.nlm.nih.gov/pubmed/31591826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12513 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|